BRIEF published on 08/01/2025 at 14:05, 1 year 1 month ago CARMAT: Resumption of Quotation and Update on Judicial Recovery Takeover Offer CARMAT Resumption Of Quotation Judicial Recovery Aeson® Artificial Heart
BRIEF published on 07/01/2025 at 20:50, 1 year 2 months ago Half-yearly report on CARMAT's liquidity contract Liquidity Contract Actions CARMAT Judicial Recovery Stockbroker
BRIEF published on 06/20/2025 at 19:15, 1 year 3 months ago CARMAT launches a donation campaign in the face of a financial crisis Funding Heart Failure Artificial Heart Financial Crisis Donation Campaign
PRESS RELEASE published on 06/20/2025 at 19:10, 1 year 3 months ago Inside Information / Other news releases CARMAT launches a donation campaign to address critical financial situation and risk of insolvency. The initiative aims to secure urgent funding for its innovative total artificial heart Financial Situation CARMAT Artificial Heart Donation Campaign Risk Of Insolvency
BRIEF published on 06/04/2025 at 17:50, 1 year 3 months ago CARMAT: Terms and conditions for the General Meeting of June 26, 2025 General Assembly Remote Voting CARMAT Artificial Heart Financial Risks
BRIEF published on 06/02/2025 at 07:05, 1 year 3 months ago CARMAT makes its first sales of artificial hearts in Israel CARMAT European Union Israel Aeson® Locations
BRIEF published on 04/09/2025 at 17:50, 1 year 5 months ago CARMAT Achieves Strong Q1 2025 Results CARMAT Q1 2025 FDA Discussions Aeson® Implants EFICAS Trial
PRESS RELEASE published on 04/09/2025 at 17:45, 1 year 5 months ago Inside Information / Other news releases CARMAT delivers strong Q1 2025 results with €2.4m sales, progresses EFICAS trial, and advances FDA discussions for EFS study in the US. Aiming for long-term patient support with enhanced heart by end of 2025 CARMAT Long-term Support FDA Discussions Q1 2025 Results EFICAS Trial
BRIEF published on 02/17/2025 at 07:05, 1 year 7 months ago CARMAT's Aeson® Artificial Heart: Promising Results for Heart Failure with Pulmonary Hypertension Medical Innovation Heart Failure Treatment Aeson® Artificial Heart Pulmonary Hypertension Transplant Eligibility
PRESS RELEASE published on 02/17/2025 at 07:00, 1 year 7 months ago Inside Information / Other news releases CARMAT's Aeson® total artificial heart, featured in The Journal of Heart and Lung Transplantation, offers a promising solution for heart failure patients with pulmonary hypertension, potentially becoming a standard treatment Heart Failure CARMAT Aeson® Pulmonary Hypertension Transplant
Published on 09/19/2026 at 00:55, 1 day 18 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 1 day 21 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 23 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 5 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/20/2026 at 15:10, 4 hours 31 minutes ago MSITEK Participates in New York Fashion Week Retail Innovation Lab
Published on 09/20/2026 at 09:05, 10 hours 37 minutes ago Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026
Published on 09/20/2026 at 06:30, 13 hours 12 minutes ago Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
Published on 09/20/2026 at 04:35, 15 hours 7 minutes ago How to Achieve Sustainable Power Without Changing Your Existing Backup System
Published on 09/19/2026 at 16:40, 1 day 3 hours ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/18/2026 at 18:34, 2 days 1 hour ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 3 days 2 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
